FDA Economic Analysis of CDRH Submission Requirements

The Food and Drug Administration (FDA) has released an economic analysis related to the submission requirements for the Center for Devices and Radiological Health (CDRH). This document, available via Regs.gov, details the economic considerations and potential impacts associated with the processes for submitting medical device applications and related materials to the FDA.

This notice serves as an informational update for medical device manufacturers and other stakeholders. While it does not impose new regulatory obligations or deadlines, it offers valuable data for understanding the costs and economic factors involved in CDRH submissions. Compliance officers should review this analysis to gain a comprehensive understanding of the economic landscape surrounding device submissions.